Cargando…

P2 receptors in atherosclerosis and postangioplasty restenosis

Mostrar otras versiones (1)

Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801–09, 1993); Fuster et al. (N Engl J Med 326:242–50, 1992); Davies and Woolf (Br Heart J 69:S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seye, Cheikh I., Kong, Qiongman, Yu, Ningpu, Gonzalez, Fernando A., Erb, Laurie, Weisman, Gary A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2007
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096770/ https://www.ncbi.nlm.nih.gov/pubmed/18404429 http://dx.doi.org/10.1007/s11302-006-9047-6

Ejemplares similares

P2 receptors in atherosclerosis and postangioplasty restenosis
por: Seye, Cheikh I., et al.
Publicado: (2006)

Postangioplasty Restenosis Followed with Magnetic Resonance Imaging in an Atherosclerotic Rabbit Model
por: Hänni, Mari, et al.
Publicado: (2012)

P2X(7) nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons
por: Kong, Qiongman, et al.
Publicado: (2005)

An Rgd Sequence in the P2y(2) Receptor Interacts with α(V)β(3) Integrins and Is Required for G(o)-Mediated Signal Transduction
por: Erb, Laurie, et al.
Publicado: (2001)

Roles of microRNAs in atherosclerosis and restenosis
por: Chen, Li-Jing, et al.
Publicado: (2012)

The P2Y(2) Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells
por: Liao, Zhongji, et al.
Publicado: (2014)

P2Y(2) receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells
por: Sathanoori, Ramasri, et al.
Publicado: (2016)

Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)
por: García-García, Héctor M., et al.
Publicado: (2011)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
por: Haidegger, Melanie, et al.
Publicado: (2021)

Deletion of P2Y(2) receptor reveals a role for lymphotoxin-α in fatty streak formation()
por: Qian, Shaomin, et al.
Publicado: (2016)

Coronary restenosis
Publicado: (1993)

Restenosis and Therapy
por: Denes, Laszlo, et al.
Publicado: (2012)

Diabetes and restenosis
por: Wilson, Scott, et al.
Publicado: (2022)

The Current State of MicroRNAs as Restenosis Biomarkers
por: Varela, Nelson, et al.
Publicado: (2020)

pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis
por: Zhu, Huiru, et al.
Publicado: (2022)

Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation
por: Lee, Hye Won, et al.
Publicado: (2013)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation
por: Woods, Lucas T., et al.
Publicado: (2015)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease
por: Karabağ, Turgut, et al.
Publicado: (2018)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
por: Ghariani, Anis, et al.
Publicado: (2022)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
por: Navarese, Eliano Pio, et al.
Publicado: (2012)

Mechanistic evaluation of long-term in-stent restenosis based on models of tissue damage and growth
por: He, Ran, et al.
Publicado: (2020)

Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis
por: Üveges, Áron, et al.
Publicado: (2019)

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis
por: Nano, Nejva, et al.
Publicado: (2022)

Nanoparticulate carriers for the treatment of coronary restenosis
por: Brito, Luis, et al.
Publicado: (2007)

miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis
por: Gutierrez-Carretero, Encarnación, et al.
Publicado: (2021)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

Perking Up Strategies to Control Restenosis
por: Riascos-Bernal, Dario F.
Publicado: (2020)

Prediction of restenosis based on hemodynamical markers in revascularized femoro-popliteal arteries during leg flexion
por: Gökgöl, Can, et al.
Publicado: (2019)

MiR-93-5p is a novel predictor of coronary in-stent restenosis
por: O'Sullivan, John F, et al.
Publicado: (2019)

Synthesis, structure-activity relationships and biological evaluation of benzimidazole derived sulfonylurea analogues as a new class of antagonists of P2Y1 receptor
por: Bano, Sehrish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o4ed6nb7geemfotfn3ic5ight3